An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use

dc.contributor.authorMulchey, Kimberley
dc.contributor.authorBshouty, Zoheir
dc.date.accessioned2016-06-08T16:03:12Z
dc.date.available2016-06-08T16:03:12Z
dc.date.issued2009-1-1
dc.date.updated2016-06-07T06:57:16Z
dc.description.abstractHepatocellular enzyme elevation is a known side effect of both bosentan and atorvastatin. However, a rise in liver enzyme level not characteristic of either agent individually may represent a reaction to their combination or an atypical reaction to bosentan alone.The present case report describes a patient who had been taking atorvastatin for many years and was started on bosentan for chronic thromboembolic pulmonary hypertension. After 19 weeks of therapy, she developed severe liver enzyme elevation that necessitated the discontinuation of both bosentan and atorvastatin. Although the safety of reintroducing bosentan in such a case is unknown, it was reintroduced in this patient because of the severity of her disease, the demonstrated treatment benefit and the lack of alternative treatment options. On reintroduction of bosentan alone, she again demonstrated significant liver enzyme elevation – this time occurring after only two doses. The present case highlights that bosentan can cause more rapid and severe hepatocellular enzyme elevation than previously believed, thus necessitating more frequent monitoring.
dc.description.versionPeer Reviewed
dc.identifier.citationKimberley Mulchey and Zoheir Bshouty, “An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use,” Canadian Respiratory Journal, vol. 16, no. 5, pp. e54-e56, 2009. doi:10.1155/2009/958617
dc.identifier.urihttp://dx.doi.org/10.1155/2009/958617
dc.identifier.urihttp://hdl.handle.net/1993/31382
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleAn Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
CRJ.2009.958617.xml
Size:
4.29 KB
Format:
Extensible Markup Language
Description:
Loading...
Thumbnail Image
Name:
CRJ.2009.958617.pdf
Size:
618.28 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description: